Soleno Therapeutics Inc. buy Guggenheim
Start price
08.05.25
/
50%
€67.90
Target price
08.05.26
€85.63
Performance (%)
-17.38%
Price
17.10.25
€56.80
Summary
This prediction is currently active. The prediction for Soleno Therapeutics Inc. disappoints with a performance of -17.38%. This prediction currently runs until 08.05.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Soleno Therapeutics Inc. | 5.185% | 5.185% |
| iShares Core DAX® | -1.072% | 2.415% |
| iShares Nasdaq 100 | 1.923% | 3.851% |
| iShares Nikkei 225® | 4.414% | 6.958% |
| iShares S&P 500 | 1.247% | 2.390% |
Comments by Guggenheim for this prediction
In the thread Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Guggenheim from $81.00 to $97.00. They now have a "buy" rating on the stock.
Ratings data for SLNO provided by MarketBeat
Stopped prediction by Guggenheim for Soleno Therapeutics Inc.
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€59.30
27.08.25
27.08.25
€91.11
27.08.26
27.08.26
-5.40%
17.10.25
17.10.25
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€69.15
07.08.25
07.08.25
€90.90
07.08.26
07.08.26
-18.87%
17.10.25
17.10.25
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€65.90
28.03.25
28.03.25
-
28.03.26
28.03.26
-14.87%
17.10.25
17.10.25
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.30
21.11.23
21.11.23
€36.55
21.11.24
21.11.24
106.38%
22.11.24
22.11.24